Condition: Irritable Bowel Syndrome · Sponsor: AbbVie
The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| HealthStar Research of Hot Springs PLLC /ID# 234609 | Hot Springs, Arkansas, United States | Recruiting |
| Applied Research Center of Arkansas /ID# 238070 | Little Rock, Arkansas, United States | Recruiting |
| Kindred Medical Institute, LLC /ID# 237368 | Corona, California, United States | Completed |
| Duplicate_VVCRD Research /ID# 234606 | Garden Grove, California, United States | Completed |
| Duplicate_Center for Clinical Trials LLC /ID# 234630 | Paramount, California, United States | Completed |
| Sunrise Research Institute /ID# 237382 | Miami, Florida, United States | Completed |
| South Miami Medical & Research Group Inc. /ID# 234655 | Miami, Florida, United States | Recruiting |
| Valencia Medical & Research Center /ID# 234672 | Miami, Florida, United States | Recruiting |
| Florida Research Center, Inc. /ID# 236514 | Miami, Florida, United States | Recruiting |
| Duplicate_Wellness Clinical Research /ID# 237401 | Miami Lakes, Florida, United States | Completed |
| Global Research Associates /ID# 234646 | Atlanta, Georgia, United States | Recruiting |
| Children's Ctr Digestive, US /ID# 237575 | Atlanta, Georgia, United States | Completed |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03339128